Effect modification by vitamin C on the relation between gastric cancer and Helicobacter pylori

被引:49
作者
Kim, DS
Lee, MS
Kim, YS
Kim, DH
Bae, JM
Shin, MH
Ahn, YO
机构
[1] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul 110799, South Korea
[2] Univ Ulsan, Coll Med, Dept Prevent Med, Ulsan, South Korea
[3] Univ Ulsan, Coll Med, Dept Family Med, Ulsan, South Korea
[4] Hallym Univ, Coll Med, Dept Social Med, Chunchon, South Korea
[5] Cheju Natl Univ, Coll Med, Dept Prevent Med, Cheju, South Korea
[6] Sungkyunkwan Univ, Sch Med, Dept Social & Prevent Med, Seoul, South Korea
关键词
ascorbic acid; case-control studies; effect modifiers; Helicobacter pylori; stomach neoplasm;
D O I
10.1007/s10654-004-1027-y
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A hospital-based case-control study of 295 cases with histologically confirmed gastric cancer and age and sex-matched controls was conducted to evaluate the effect of dietary vitamin C intake upon the relation between Helicobacter pylori infection and gastric cancer in Korea in 1997-1998. Anti-H. pylori IgG was detected by ELISA. A food frequency questionnaire, and a questionnaire on demographic factors, including past medical history, smoking, alcohol consumption, and life style was also administered. The prevalences of H. pylori IgG in cases and controls were 80.7% and 71.2%, respectively, and the odds ratio (OR) of H. pylori for gastric cancer was 1.68 (95% confidence interval (CI): 1.14, 2.44), after adjusting for age, sex, educational level, and a past medical history of gastritis or gastric ulcer. In a stratified analysis, H. pylori seropositivity was found to be a significant risk factor for gastric cancer in the low vitamin C intake group (OR=4.68; 95% CI: 1.97, 11.1), but not in the high vitamin C intake group (OR=0.72; 95% CI: 0.32, 1.65). Vitamin C intake was found to modify the relation between H. pylori and gastric cancer.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 36 条
[1]  
[Anonymous], 1982, CASE CONTROL STUDIES
[2]   EFFECT OF HELICOBACTER-PYLORI AND ITS ERADICATION ON GASTRIC-JUICE ASCORBIC-ACID [J].
BANERJEE, S ;
HAWKSBY, C ;
MILLER, S ;
DAHILL, S ;
BEATTIE, AD ;
MCCOLL, KEL .
GUT, 1994, 35 (03) :317-322
[3]  
BLASER MJ, 1995, CANCER RES, V55, P2111
[4]   Review article: antioxidant micronutrients and gastric cancer [J].
Correa, P ;
Malcom, G ;
Schmidt, B ;
Fontham, E ;
Ruiz, B ;
Bravo, JC ;
Bravo, LE ;
Zarama, G ;
Realpe, JL .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 :73-82
[5]   Chemoprevention of gastric dysplasia:: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy [J].
Correa, P ;
Fontham, ETH ;
Bravo, JC ;
Bravo, LE ;
Ruiz, B ;
Zarama, G ;
Realpe, JL ;
Malcom, GT ;
Li, D ;
Johnson, WD ;
Mera, R .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (23) :1881-1888
[6]  
CORREA P, 1990, CANCER-AM CANCER SOC, V66, P2569, DOI 10.1002/1097-0142(19901215)66:12<2569::AID-CNCR2820661220>3.0.CO
[7]  
2-I
[8]   GEOGRAPHIC ASSOCIATION OF HELICOBACTER-PYLORI ANTIBODY PREVALENCE AND GASTRIC-CANCER MORTALITY IN RURAL CHINA [J].
FORMAN, D ;
SITAS, F ;
NEWELL, DG ;
STACEY, AR ;
BOREHAM, J ;
PETO, R ;
CAMPBELL, TC ;
LI, J ;
CHEN, J .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (04) :608-611
[9]  
FORMAN D, 1993, LANCET, V341, P1359
[10]   HELICOBACTER-PYLORI INFECTION AND CHRONIC ATROPHIC GASTRITIS AMONG JAPANESE BLOOD-DONORS - A CROSS-SECTIONAL STUDY [J].
FUKAO, A ;
KOMATSU, S ;
TSUBONO, Y ;
HISAMICHI, S ;
OHORI, H ;
KIZAWA, T ;
OHSATO, N ;
FUJINO, N ;
ENDO, N ;
IHA, M .
CANCER CAUSES & CONTROL, 1993, 4 (04) :307-312